UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection

Annals of surgical oncology, 2012-02, Vol.19 (2), p.597-604

2012

Volltextzugriff (PDF)

Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial

Annals of surgical oncology, 2006-12, Vol.13 (12), p.1702-1710

2006

Volltextzugriff (PDF)

Diagnosis of breast cancer with infrared spectroscopy from serum samples

Vibrational spectroscopy, 2010-03, Vol.52 (2), p.173-177

2010

Volltextzugriff (PDF)

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

Oncology, 2006-05, Vol.70 (2), p.141-146

2006

Volltextzugriff (PDF)

Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer

Oncology, 2010-01, Vol.79 (3-4), p.197-203

2010

Volltextzugriff (PDF)

Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel plus Doxorubicin (D4) for First-Line Treatment of Metastatic Breast Cancer

Oncology, 2010-01, Vol.79 (3-4), p.204-210

2010

Volltextzugriff (PDF)

Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes : a new approach to cancer immunotherapy

Cancer research (Chicago, Ill.), 1990-12, Vol.50 (23), p.7450-7456

1990

Volltextzugriff (PDF)

Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy

Supportive care in cancer, 1999-09, Vol.7 (5), p.354-361

1999

Volltextzugriff (PDF)

Praxis der gynäkologischen Onkologie

2. aktualisierte Auflage.

Volltextzugriff (PDF)

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m2 Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

Oncology, 2006, Vol.70 (2), p.141-146

2006

Volltextzugriff (PDF)

Susceptibility of malignant and normal target cells to the cytotoxic action of bone-marrow macrophages activated in vitro with the macrophage cytotoxicity factor (MCF)

Cellular immunology, 1978-12, Vol.41 (2), p.231-239

1978

Volltextzugriff (PDF)

Neoadjuvant therapy for cervical cancer

Seminars in oncology, 1992-02, Vol.19 (1 Suppl 2), p.94

1992

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(14)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Aged
(11)
Female
(11)
Humans
(11)
Middle Aged
(11)
Adult
(10)
Science & Technology
(10)
Life Sciences & Biomedicine
(9)
Oncology
(9)
Aged, 80 And Over
(6)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Breast Cancer
(4)
Breast Neoplasms - Drug Therapy
(4)
Breast Neoplasms - Pathology
(4)
Gynecology. Andrology. Obstetrics
(4)
Survival Rate
(4)
Treatment Outcome
(4)
Tumors
(4)
Chemotherapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection

Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial

Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group

First-Line Trastuzumab Plus Epirubicin and Cyclophosphamide Therapy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Cardiac Safety and Efficacy Data From the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) Trial

Diagnosis of breast cancer with infrared spectroscopy from serum samples

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer

Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel plus Doxorubicin (D4) for First-Line Treatment of Metastatic Breast Cancer

Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial

Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes : a new approach to cancer immunotherapy

Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy

Praxis der gynäkologischen Onkologie

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m2 Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

Susceptibility of malignant and normal target cells to the cytotoxic action of bone-marrow macrophages activated in vitro with the macrophage cytotoxicity factor (MCF)

Neoadjuvant therapy for cervical cancer

Suchergebnisse filtern